These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9300806)

  • 1. Polysialylated asparaginase: preparation, activity and pharmacokinetics.
    Fernandes AI; Gregoriadis G
    Biochim Biophys Acta; 1997 Aug; 1341(1):26-34. PubMed ID: 9300806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics.
    Fernandes AI; Gregoriadis G
    Int J Pharm; 2001 Apr; 217(1-2):215-24. PubMed ID: 11292557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics.
    Gregoriadis G; Fernandes A; Mital M; McCormack B
    Cell Mol Life Sci; 2000 Dec; 57(13-14):1964-9. PubMed ID: 11215521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification of L-asparaginase with colominic acid and the new characteristics of the modified enzyme].
    Wang YD; Guo L; Qian SJ; Meng GZ; Zhang SZ
    Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):517-20. PubMed ID: 11051832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
    Qian G; Zhou J; Ma J; Wang D; He B
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):567-77. PubMed ID: 8922226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysialic acids: potential role in therapeutic constructs.
    Gregoriadis G; Fernandes A; McCormack B; Mital M; Zhang X
    Biotechnol Genet Eng Rev; 1999; 16():203-15. PubMed ID: 10819079
    [No Abstract]   [Full Text] [Related]  

  • 7. Polysialylated insulin: synthesis, characterization and biological activity in vivo.
    Jain S; Hreczuk-Hirst DH; McCormack B; Mital M; Epenetos A; Laing P; Gregoriadis G
    Biochim Biophys Acta; 2003 Jun; 1622(1):42-9. PubMed ID: 12829260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructure L-asparaginase-fatty acid bioconjugate: synthesis, preformulation study and biological assessment.
    Ashrafi H; Amini M; Mohammadi-Samani S; Ghasemi Y; Azadi A; Tabandeh MR; Kamali-Sarvestani E; Daneshamouz S
    Int J Biol Macromol; 2013 Nov; 62():180-7. PubMed ID: 23994737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PEG-chitosan branched copolymers to improve the biocatalytic properties of Erwinia carotovora recombinant L-asparaginase].
    Kudryashova EV; Suhoverkov KV; Sokolov NN
    Biomed Khim; 2015; 61(4):480-7. PubMed ID: 26350739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and properties of sialylated catalase.
    Fernandes AI; Gregoriadis G
    Biochim Biophys Acta; 1996 Mar; 1293(1):90-6. PubMed ID: 8652633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and preliminary characterization of L-asparaginase from Erwinia aroideae NRRL B-138.
    Tiwari N; Dua RD
    Indian J Biochem Biophys; 1996 Oct; 33(5):371-6. PubMed ID: 9029817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
    Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
    J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional insights into Erwinia carotovora L-asparaginase.
    Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
    FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: I: Preparation and in vitro characterization.
    Jean-François J; Fortier G
    Biotechnol Appl Biochem; 1996 Jun; 23(3):221-6. PubMed ID: 8679108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
    J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
    Uren JR; Hargis BJ; Beardsley P
    Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
    O'Driscoll KF; Korus RA; Ohnuma T; Walczack IM
    J Pharmacol Exp Ther; 1975 Nov; 195(2):382-8. PubMed ID: 241845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
    Kotzia GA; Labrou NE
    J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TK1656, a thermostable l-asparaginase from Thermococcus kodakaraensis, exhibiting highest ever reported enzyme activity.
    Chohan SM; Rashid N
    J Biosci Bioeng; 2013 Oct; 116(4):438-43. PubMed ID: 23648103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering thermal stability of L-asparaginase by in vitro directed evolution.
    Kotzia GA; Labrou NE
    FEBS J; 2009 Mar; 276(6):1750-61. PubMed ID: 19220855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.